期刊文献+

2,3-二甲基-6-氨基-2H-吲唑的合成研究 被引量:1

A Study on the Synthesis of 2,3-diethyl-6-nitro-2H-indazole
下载PDF
导出
摘要 目的:设计与合成具有分子靶向性、低毒高效新型血管生成抑制剂类抗肿瘤药物中间体。方法:以2-乙基苯胺为原料经醋酐酰化、浓硝酸低温硝化及去酰基保护合成2-乙基-5-硝基苯胺,后用亚硝酸钠关环得3-甲基-6-硝基-1H-吲唑,经硫酸二甲酯甲基化得2,3-二甲基-6-硝基-2H-吲唑,最后用氯化亚锡将其还原得到目标产物,通过1HNMR确定结构与目标产物一致。结果:所用的合成方法可靠,质量可控,总收率为15.7%。结论:所采用合成方法能用于2,3-二甲基-6-氨基-2H-吲唑的制备。 Objective: To design and synthesize a key intermediate of novel molecule-targeting angiogenesis inhibitor with potent anti-tumor activity and low toxicity. Methods: 2-ethyl aniline was used as starting material of the synthesis and was processed by acetic anhydride acylation, strong nitric acid hitraction at low temperature, and desacyl synthesis to produce 2-ethyl-5-nitro aniline. The product was then synthesized to 3-methyl-6-nitro-1H-indazole by using ring-closing reaction in the presence of NaNO2, and then ethylated to obtain 2,3-diethyl-6- nitro-2H-indazole. The latter compound was then reduced by SnCl2/Hcl to get target compound 2,3-diethyl-6-nitro-2H-indazole. Result: The obtained compound was identified as the target one by ^1H NMR. Conclusion: The route was suitable for the preparation of 2,3 -diethyl-6-nitro-2 H -indazole.
出处 《贵阳医学院学报》 CAS 2010年第1期44-46,共3页 Journal of Guiyang Medical College
关键词 抗肿瘤药 2 3-二甲基-6-氨基-2H-吲唑 合成 中间体 antineoplastic agents 2,3-diethy1-6-nitro-2H-indazole synthesis intermediate
  • 相关文献

参考文献7

  • 1Folkman J. The role of angiogenesis in tumor growth [ J ]. Semmin Cancer Biol,1992 (2) :65 -71.
  • 2Veikkola T, Karkkainen M, Claesson-Welsh L,et al. Regulation of angiogenesis via vascular endothelial growth factor receptors [ J ]. Cancer Res,2000 (60) : 203 - 212.
  • 3Hanahan D, folkman J. Patterms and emerging mechanisms of the angiogenic switch during tumorigenesis [ J ]. Cell, 1996 ( 3 ) : 353 - 354.
  • 4Sonpavde G, Hutson T E. Pazopanib: a novel muhitargeted tyrosine kinase inhibitor [ J ]. Curr Oncol Rep, 2007 (9) :115 -119.
  • 5John T Hunt. Discover of the Pyrrolo[ 1,2,4 ] triazine Nucleus as a New Kinase Inhibitor [ J ]. Med Chem, 2004 ( 47 ) :4054 - 4059.
  • 6Baka S, Clamp A R, Jayson G C. A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis [ J ]. Expert Opin Ther Targets, 2006 ( 10 ) : 867 - 876.
  • 7陈年根,刘新泳,任兆平.5-羟基-5H-[1]-苯并吡喃[2,3-b]吡啶的制备[J].华西药学杂志,2008,23(2):166-167. 被引量:8

二级参考文献2

  • 1[1]苏焕臣,曲秉杰,李晓东编译.药物制造百科全书[M].长春:长春出版社,1991.734.
  • 2[4]Mann FG,Reid JA.The preparation and properties of 9-oxa-1-aza-anthroneand 9-thia-1-8aza-anthrone[J].J Chem Soc,1952:2057-2062.

共引文献7

同被引文献5

  • 1易奋飞.1H-吲唑类化合物的合成方法改进及IGF-1R抑制剂的合成[D].成都:西南石油大学,2012.
  • 2JOHN S K, ME C S, JOSEPHINE C S. New Ofloxacin type antibacterial agents incorporation of the spiro cyclopropyl group at N-1 [J]. J Med Chem,1988,31:2004-2008.
  • 3中国科学院上海药物研究所.合成手性2-取代哌嗪及其衍生物的方法[P]:中国,发明专利,CNl629146A.2003.
  • 4GIOVANNI B P,BARBARA C,GIAMPIERO S, et al. A new synthetic approach to indazole synthesis [J]. Synthesis, 1997 (10) : 1140-1142.
  • 5曲毅,张宇,张辰.吲唑类化合物合成研究进展[J].浙江化工,2012,43(3):10-14. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部